BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10915924)

  • 1. Chitosan microspheres in PLG films as devices for cytarabine release.
    Blanco MD; Gómez C; Olmo R; Muñiz E; Teijón JM
    Int J Pharm; 2000 Jul; 202(1-2):29-39. PubMed ID: 10915924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) film: in vitro and in vivo studies.
    Gómez C; Blanco MD; Bernardo MV; Olmo R; Muñiz E; Teijón JM
    Eur J Pharm Biopharm; 2004 Mar; 57(2):225-33. PubMed ID: 15018979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupivacaine-loaded comatrix formed by albumin microspheres included in a poly(lactide-co-glycolide) film: in vivo biocompatibility and drug release studies.
    Blanco MD; Bernardo MV; Gómez C; Muñiz E; Teijón JM
    Biomaterials; 1999 Oct; 20(20):1919-24. PubMed ID: 10514068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release of bupivacaine from devices based on chitosan.
    Bernardo MV; Blanco MD; Sastre RL; Teijón C; Teijón JM
    Farmaco; 2003 Nov; 58(11):1187-91. PubMed ID: 14572870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of Bordetella bronchiseptica dermonecrotoxin (BBD) vaccine from BBD-loaded chitosan microspheres in vitro.
    Jiang HL; Park IK; Shin NR; Yoo HS; Akaike T; Cho CS
    Arch Pharm Res; 2004 Mar; 27(3):346-50. PubMed ID: 15089042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils.
    Hejazi R; Amiji M
    Pharm Dev Technol; 2003 Aug; 8(3):253-62. PubMed ID: 12901691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
    Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.
    Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2871-3. PubMed ID: 2076575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
    Thanoo BC; Sunny MC; Jayakrishnan A
    J Pharm Pharmacol; 1992 Apr; 44(4):283-6. PubMed ID: 1355537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of chitosan microspheres containing doxifluridine.
    Yoshino T; Machida Y; Onishi H; Nagai T
    Drug Dev Ind Pharm; 2003 Apr; 29(4):417-27. PubMed ID: 12737535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-based thermosensitive hydrogel containing liposomes for sustained delivery of cytarabine.
    Mulik R; Kulkarni V; Murthy RS
    Drug Dev Ind Pharm; 2009 Jan; 35(1):49-56. PubMed ID: 18821152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Internal pharmacokinetical study on genistein chitosan microsphere capsule].
    Wu W; Li Y
    Zhong Yao Cai; 2002 Apr; 25(4):282-4. PubMed ID: 12583183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres.
    Sturesson C; Artursson P; Ghaderi R; Johansen K; Mirazimi A; Uhnoo I; Svensson L; Albertsson AC; Carlfors J
    J Control Release; 1999 Jun; 59(3):377-89. PubMed ID: 10332067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies.
    Elçin YM; Dixit V; Gitnick G
    Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):257-71. PubMed ID: 8773742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs.
    Jameela SR; Misra A; Jayakrishnan A
    J Biomater Sci Polym Ed; 1994; 6(7):621-32. PubMed ID: 7873513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of interleukin-2 from chitosan microspheres.
    Ozbaş-Turan S; Akbuğa J; Aral C
    J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release.
    Goraltchouk A; Scanga V; Morshead CM; Shoichet MS
    J Control Release; 2006 Jan; 110(2):400-407. PubMed ID: 16325953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
    Ko JA; Park HJ; Hwang SJ; Park JB; Lee JS
    Int J Pharm; 2002 Dec; 249(1-2):165-74. PubMed ID: 12433445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.